Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 06, 2023

Plasma VEGF Levels Do Not Predict Tumor Growth in Patients With von Hippel–Lindau Disease

PloS One


Additional Info

PloS One
Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
PLoS ONE 2022 Feb 01;17(11)e0278166, J Sundblom, TP Skare, O Holm, S Welin, M Braun, P Nilsson, P Enblad, EO Sjöström, A Smits

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading